Press Releases

The latest news from Clinithink.

Northwell Health Adopts Clinithink Technology to Accelerate Patient Identification for Clinical Trials

Posted by Clinithink on 14/03/2019

Clinithink’s CLiX accelerate is now implemented and showing significant improvement in identifying candidates for clinical trials and research at one of the largest health systems in the US.

Northwell Health is far more than a health system. A phenomenal centre of talent and excellence the organization cares for a service area of eight million people, across 23 hospitals and more than 700 outpatient locations. Northwell has 68,000 employees, including more than 30,000 physicians and nurses operating across a huge range of specialties.

Northwell is also the home of The Feinstein Institute for Medical Research – a collaboration of creative thinkers who share a singular focus of advancing science to prevent disease and cure patients. Northwell’s overarching focus is on changing healthcare – not just by discovering the latest medical and scientific advancements, or by training the doctors of tomorrow, but by adopting innovative new software like CLiX to reinvent their approach to clinical research.

Serving one of the most diverse patient populations in the US, Northwell Health has been quick to recognise that the adoption of AI and NLP technologies like CLiX could reinvent the clinical trial feasibility model – enabling the rapid identification of potential patients for clinical trial that had simply been missed before.

And CLiX is now providing the deepest, fastest and most accurate analysis of unstructured patient data ever seen at Northwell – successfully identifying candidates for clinical trials in hours not months.

In a proof of concept study of COPD at Northwell the total patient cohort considered was 939,378 patients and there were 3.3 million associated documents for review. CLiX accelerate assessed these patients against 22 individual criteria in just 30 hours – a fraction of the time it would have taken previously – producing an impressive 88 patients to review, all of whom were highly relevant to the trial.

Elaine Brennan, Managing Director of Pharma Ventures at Northwell Health, said:  "What is really exciting about working with CLiX accelerate is that it allows us to mine a much richer data set and identify potential patients across our entire network, not just the specific location where the study is being conducted.  Leveraging tools to support the patient identification and enrollment process is part of Northwell's strategic goals to make clinical trials an option for patients and to make Northwell a premier destination for clinical trials."

What’s more, CLiX accelerate has been easy to adopt at Northwell Health. The software effortlessly drills down to a granular level, that has only previously been possible by manual review, thereby dramatically speeding up the decision making process for the reviewer. In addition, as our lists focus pre-screening on those patients most likely to qualify for the clinical trial, Northwell has found that they have eliminated the ‘data noise’ they often experienced previously.

Sarah Beeby, EVP, GM Life Sciences for Clinithink said:  “Northwell Health is a superb addition to Clinithink’s network. The strategic alliance between ourselves and Northwell recognises that narrative clinical data is a huge untapped asset for health systems around the world, and the fact that our technology enables Northwell to really leverage the breadth and depth of their immensely diverse patient population to rapidly identify potential patients for trial is a fact we are very proud of indeed.”

For further information on Clinithink’s work with Northwell, or on what CLiX accelerate software can do for your clinical trials, please contact

 About Clinithink 

CLiX delivers the deepest, fastest and most accurate analysis of unstructured data across patient populations currently possible. This analysis provides medical professionals with the knowledge they need to quickly and accurately diagnose conditions and plan the most effective treatments. It enables our healthcare partners to provide optimal care to patients that is swiftly reimbursed, protecting their ability to deliver care to the people who need it most.  And it can also fast forward drug development; ensuring protocols are optimized, patients matched and sites identified in a fraction of the time of manual processing – helping our life science associates get the treatments patients need to market faster. For further information visit


About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, more than 700 outpatient facilities and more than 13,600 affiliated physicians. Northwell cares for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from Northwell’s communities. Northwell’s 68,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. They are making breakthroughs in medicine at the Feinstein Institute for Medical Research. They are training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and at the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For further information visit


- Ends -



Topics: Publications